Moreover, the cytotoxic effects of Os appeared to be more pronounced in CRC cells compared to normal colonic epithelial cells, as evidenced by the response of the FHC cell line (IC50 ~ 90 μM), suggesting the presence of a therapeutic window exploitable for CRC treatment. The gene discussed is MID1; the disease is colorectal carcinoma.